Alterations of the p53 gene in nasopharyngeal carcinoma
- PMID: 1349927
- PMCID: PMC241162
- DOI: 10.1128/JVI.66.6.3768-3775.1992
Alterations of the p53 gene in nasopharyngeal carcinoma
Abstract
Nasopharyngeal carcinoma (NPC) is a malignancy which is consistently associated with the Epstein-Barr virus (EBV). The structure of the EBV genome in NPC suggests that NPC is a clonal proliferation of epithelial cells which emerges after EBV infection. The disease develops with high incidence in specific populations in discrete geographic locations, implicating possible genetic or environmental cofactors. Mutations of the p53 gene are among the most frequent genetic changes found in a large variety of human tumors. Mutations in p53 have been shown to abrogate the suppressor function of wild-type p53 and thus contribute to the transformed phenotype. To determine if mutation in p53 participates in the development of the malignant clone in NPC, the structure and sequence of p53 in 42 primary, metastatic, and nude mouse-passaged NPC specimens was analyzed. A high frequency (6 of 9) of mutations was detected in the nude mouse-passaged tumors, while only 2 of 15 metastatic and 0 of the 18 primary tumors harbored mutant p53. The p53 mutations included single-point mutations and more extensive changes such as frame shifts, deletion, duplication, or complete loss of coding sequences. These data indicate that alterations of the p53 gene are unlikely to be involved in the initial genetic events leading to the clonal outgrowth in NPC. However, although it is a rare NPC which can be established in nude mice, this growth advantage appears to be conferred on tumors bearing a mutant p53.
Similar articles
-
A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients.Cancer Lett. 1994 Jul 29;82(2):189-98. doi: 10.1016/0304-3835(94)90011-6. Cancer Lett. 1994. PMID: 7914150
-
Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.Oncogene. 1992 Nov;7(11):2131-40. Oncogene. 1992. PMID: 1331932
-
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.J Virol. 1992 May;66(5):2689-97. doi: 10.1128/JVI.66.5.2689-2697.1992. J Virol. 1992. PMID: 1313894 Free PMC article.
-
Epstein-Barr virus and nasopharyngeal carcinoma: bringing molecular genetics strategies to head and neck oncology.J Otolaryngol. 1994 Apr;23(2):130-4. J Otolaryngol. 1994. PMID: 8028071 Review.
-
Epstein-Barr virus and nasopharyngeal carcinoma.Semin Cancer Biol. 1992 Oct;3(5):297-307. Semin Cancer Biol. 1992. PMID: 1335793 Review.
Cited by
-
The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner.J Virol. 2011 May;85(9):4318-29. doi: 10.1128/JVI.01856-10. Epub 2011 Feb 16. J Virol. 2011. PMID: 21325409 Free PMC article.
-
Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.J Virol. 1996 Dec;70(12):8653-9. doi: 10.1128/JVI.70.12.8653-8659.1996. J Virol. 1996. PMID: 8970991 Free PMC article.
-
Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.Sci Rep. 2017 Mar 3;7:42980. doi: 10.1038/srep42980. Sci Rep. 2017. PMID: 28256603 Free PMC article.
-
Helicobacter pylori and Epstein-Barr Virus Co-Infection in Gastric Disease: What Is the Correlation with p53 Mutation, Genes Methylation and Microsatellite Instability in a Cohort of Sicilian Population?Int J Mol Sci. 2023 Apr 30;24(9):8104. doi: 10.3390/ijms24098104. Int J Mol Sci. 2023. PMID: 37175810 Free PMC article.
-
MDM-2 protein expression in nasopharyngeal carcinomas. Comparative study with p53 protein expression.Clin Mol Pathol. 1995 Dec;48(6):M322-5. doi: 10.1136/mp.48.6.m322. Clin Mol Pathol. 1995. PMID: 16696032 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous